NovoCure Ltd (NVCR) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $82.89M2017: $177.03M2018: $248.07M2019: $351.32M2020: $494.37M2021: $535.03M2022: $537.84M2023: $509.34M2024: $605.22M2025: $655.35M$655.35M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$655.35M+8.3%
2024$605.22M+18.8%
2023$509.34M-5.3%
2022$537.84M+0.5%
2021$535.03M+8.2%
2020$494.37M+40.7%
2019$351.32M+41.6%
2018$248.07M+40.1%
2017$177.03M+113.6%
2016$82.89M